Posttransplant infections in the tropical countries.
Over half of all renal transplant recipients in the tropical countries develop a serious infection at some point in the posttransplant period and 20% to 40% of them succumb to these infections. Many of these infections are endemic to the region. A multitude of factors including unhygienic conditions, hot and humid climate, late presentation, lack of knowledge about the spectrum of organisms in these areas, scanty diagnostic techniques, and high cost of lifesaving antimicrobial agents contribute to this dismal outcome. Tuberculosis is observed in 10% to 15% of transplant recipients. Pleuropulmonary disease is most frequent, but the commonly employed tests are seldom helpful in the diagnosis. Bronchoalveolar lavage is very sensitive in early detection of this infection and allows timely institution of specific therapy. Hepatitis virus infections are generally acquired before transplant, and viral replication is accelerated under the effect of immunosuppressive therapy leading to chronic liver disease. Cytomegalovirus (CMV) disease has shown a fourfold increase after introduction of cyclosporine to the immunosuppressive regimes at our center. Coinfection with other bacteria or fungi is frequent in CMV-infected allograft recipients. Opportunistic fungal infections are seen in less than 10% of allograft recipients, but this figure is likely an underestimate. The frequently encountered fungal infections include Candida, Aspergillus, Cryptococcus, and Mucor. Fungal infections carried a high mortality of over 65% at our center. The protean manifestations of the opportunistic infections and nonavailability of sensitive diagnostic tests in most centers in the underdeveloped countries often delay the diagnosis and institution of therapy.
Jha
Vivekanand
V
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. chughks@sancharnet.in
Chugh
Kirpal S
KS
D001424:Bacterial Infections / Q000209:etiology / Q000628:therapy; D006801:Humans; D007239:Infections / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D016030:Kidney Transplantation / Q000009:adverse effects*; D009181:Mycoses / Q000209:etiology / Q000628:therapy; D010272:Parasitic Diseases / Q000209:etiology; D011183:Postoperative Complications; D014330:Tropical Medicine; D014376:Tuberculosis / Q000209:etiology / Q000628:therapy; D014777:Virus Diseases / Q000209:etiology / Q000628:therapy